# PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram

> **NCT00250172** · PHASE1 · COMPLETED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 26 (actual)

## Conditions studied

- Dosimetry
- Healthy

## Interventions

- **DRUG:** [C-11](R)-rolipram

## Key facts

- **NCT ID:** NCT00250172
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10-31
- **Primary completion:** 2009-02-05
- **Final completion:** 2009-02-05
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00250172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00250172, "PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram". Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/clinical/NCT00250172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*